logo
Plus   Neg
Share
Email

Glu Mobile Unveils Real-Money Gambling Offering With Probability; Stock Surges

Glu Mobile Inc. (GLUU), a developer and publisher of freemium games for smartphone and tablet devices, announced the availability of its first real-money mobile gambling offering through Probability Plc. (PBTY.L), the mobile entertainment gambling provider.

The mobile slot game features intellectual property from Glu's Samurai vs. Zombies Defense and is made available to mobile real-money gamers in the UK through Probability's distribution network.

"We are pleased to expand our mobile portfolio to include real-money gambling. We anticipate that real-money gambling will continue to gain momentum globally and believe that with this offering, Glu is well positioned to capitalize to the extent that additional markets adjust regulations," said Niccolo de Masi, Chief Executive Officer of Glu Mobile.

Glu Mobile said that the company and Probability entered into a strategic relationship for real-money gambling in 2012 and plan to offer additional Glu-branded mobile gambling games. Glu original IP-branded casino games will be offered as part of the Probability portfolio and will be offered to a broad range of Probability's partners such as Paddy Power, William Hill, and Probability's white label partners.

GLUU closed Monday's trading at $2.42. In Tuesday's pre-market trading, the company's shares are up $0.48 or 19.83 percent to $2.90.

by RTTNews Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
An administrative law judge has ruled that Minnesota regulators should approve Enbridge Inc.'s proposal to replace its aging Line 3 crude oil pipeline only if the company follows the existing route and not its preferred route. Enbridge has applied to replace its Line 3 pipeline from Alberta with new pipe along its existing route. In Minnesota, the planned route deviates from the existing route. CLICK HERE to see America's 10 Best-Selling Drugs Despite high drug costs, most of the top-selling drugs saw sales gains in 2017 compared to the prior year. A large number of the best-selling drugs are primarily for the treatment and management of cancer, diabetes, inflammatory disorders, and HIV... Most Americans have access to health care, though costs and services vary from state to state. However, higher costs do not necessarily translate into better results. The U.S. continues to be outperformed by other wealthy nations on several measures like life expectancy, disease burden and health...
Follow RTT